Solis mammography cy fair houston registration#

Solis mammography cy fair houston registration#

Any reference herein to the Registration Statement, the

The Securities, and the term Preliminary Prospectus means the preliminary prospectus supplement specifically relating to the Securities together with the Base Prospectus. Prospectus as supplemented by the Prospectus Supplement specifically relating to the Securities in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Act) in connection with the confirmation and sales of Such registration statement, including any required information deemed to be a part thereofĪt the time of effectiveness pursuant to Rule 430A, 430B or 430C under the Act (the Rule 430 Information), is called the Registration Statement. The term Prospectus shall mean the Base The Company has also filed or proposed to file, with theĬommission pursuant to Rule 424 under the Act a prospectus supplement specifically relating to the Securities (the Prospectus Supplement). Statement contains a base prospectus relating to the debt securities, including the Securities, to be issued from time to time by the Company (the Base Prospectus). In connection with the offer and sale of the Securities, the Company and the Guarantors have prepared andįiled with the Securities and Exchange Commission (the Commission) a registration statement on Form S-3 (File No. 333-226709), which registration Subsidiary Guarantors and the Parent Guarantor shall be collectively referred to herein as the Guarantors. Guarantors) and (ii) on a senior unsecured basis by the Parent Guarantor (the Parent Guarantee and, together with the Subsidiary Guarantees, the Guarantees). Subsidiaries that guarantee only the asset-based revolving credit facility) (the Credit Facilities) described in the Disclosure Package (as defined below) and the Prospectus (as defined below) (together, the Subsidiary Subsidiary Guarantees) by each of the Companys subsidiaries (as defined in Section 18 hereof) that guarantee the Companys obligations under the senior secured credit facilities (with the exception of the The Securities will be unconditionally guaranteed (i) jointly and severally, on a senior secured basis (the Indenture as so supplemented, the 2031 Securities Indenture) and (ii) with respect to the 2051 Securities, the twenty-eighth supplemental indenture relating to the 2051 Securities, to be dated June 30, 2021, among theĬompany, the Guarantors, the Trustee and the Registrar (the Base Indenture as so supplemented, the 2051 Securities Indenture and, together with the 2031 Securities Indenture, each, an Indenture and together, the (i) with respect to the 2031 Securities, the twenty-seventh supplemental indenture relating to the 2031 Securities, to be dated June 30, 2021, among the Company, the Guarantors (as defined below), the Trustee and the Registrar (the Base Trustee (in such capacity, the Trustee), and Deutsche Bank Trust Company Americas, as registrar, paying agent and transfer agent (the Registrar) (the Base Indenture), as supplemented by The Securities will be issued pursuant to a base indenture, datedĪugust 1, 2011, among the Company, HCA Healthcare, Inc., a Delaware corporation and the Companys parent (the Parent Guarantor), Delaware Trust Company (as successor to Law Debenture Trust Company of New York), as HCA Inc., a Delaware corporation (the Company), proposes to issue and sell to the several parties named in Schedule I hereto (eachĪn Underwriter and together, the Underwriters), for whom you (the Representatives) are acting as representatives, the respective amounts set forth in such Schedule I of (i) $850,000,000Īggregate principal amount of its 2 3/8% Senior Secured Notes due 2031 (the 2031 Securities) and (ii) $1,500,000,000 aggregate principal amount of its 3 1/2% Senior Secured Notes due 2051 (the 2051 SecuritiesĪnd, together with the 2031 Securities, the Securities).